Corvus Pharmaceuticals Inc. (CRVS) will present final data from its Phase 1/1b trial of soquelitinib in patients with T cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback